Video

Educated Patient® Skin Cancer Summit: June 26, 2021

Author(s):

CURE Media Group

View the full CURE Educated Patient Skin Cancer Summit on demand.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Image of man with text.
Related Content
Image of skin cells.
August 19th 2025

Cylembio Plus Keytruda Extends PFS in Trial For Advanced Melanoma

Ryan Scott
CURE Cancer Horizons logo
August 19th 2025

FDA Approvals from February 2024

Alex Biese Brielle Benyon
Adding SCIB1 or iSCIB1+ to standard treatments helped more patients with advanced melanoma respond and live longer without extra side effects: © stock.adobe.com.
August 19th 2025

New Treatment Combo Improves Advanced Melanoma Outcomes

Spencer Feldman
Top Cancer Headlines from 2023
August 19th 2025

Top Cancer Headlines from 2023

Alex Biese Brielle Benyon
Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe subtypes: © stock.adobe.com.
August 19th 2025

Clinical Trial Confirms Keytruda and Lenvima Benefit in Kidney Cancer

Russ Conroy
Stereotactic body radiotherapy costs less and has shown better safety compared with immunotherapy and tyrosine kinase inhibitors in patients kidney cancer: © stock.adobe.com
August 19th 2025

Metastasis-Directed Radiotherapy Shows Improved Kidney Cancer Outcomes

Tim Cortese